Skip to main content

Spectral Medical Inc(EDT-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Spectral Medical Inc down on Thursday (EDT)

Automated Summaries - The Globe and Mail - Thu Apr 4, 4:02PM CDT

In market activity today, Spectral Medical Inc shares closed at $0.41 after opening the day at $0.41. It traded at a low of $0.41 to a high of $0.42.

The price dipped -4.65% from the previous day's close of $0.43.

During the day across North America, the TSX Composite closed 0.17% at 22112.46, the S&P 500 closed 0.11% at 5211.49, the Dow Jones Industrial Average closed -0.11% at 39127.14 and the Nasdaq Composite closed 0.23% at 16277.46.

Spectral Medical Inc traded under EDT on the Toronto Stock Exchange (TSX).

Trading volume was 131,819 on 137 total trades. On average, Spectral Medical Inc has traded 58,656 shares in the last five days and 116,918 year-to-date.

Trading across the entire TSX saw 1,535 price advancers against 3,670 declines and 135 unchanged.

During the prior 52 weeks, EDT.TO has traded as high as $0.67 (February 07,2024) and low as $0.23 (June 14,2023). Moreover, in the last 52 weeks, Spectral Medical Inc's shares have soared 28.13 percent, while they have shrunken -3.53% this year.

It announced a 0.12 dividend on November 29/11, with an December 19/11 ex-date and January 20/12 pay day.

Following today's trading, Spectral Medical Inc has a market capitalization of $119.79 million on a float of 278,576 shares outstanding. Its annual EPS is $-0.06.

Spectral Medical Inc is a None company headquartered in Toronto, CAN.

Currently, Spectral Medical Inc's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe